Skip to Content

Nidale Tarek, MD

Present Title & Affiliation

Primary Appointment

Assistant Professor, Department of Pediatrics Patient Care, Division of Pediatrics, The University of Texas MD Anderson Cancer Center, Houston, TX

Education & Training

Degree-Granting Education

2004 Lebanese University of Beirut, Lebanon, MD, Medicine

Postgraduate Training

2008-2011 Fellowship, Pediatric Hematology Oncology, Memorial Sloan-Kettering Cancer Center and The New York Hospital, New York, NY
2006-2008 Residency, Pediatrics, SUNY-Downstate Medical Center, Brooklyn, NY
2005-2006 Internship, Pediatrics, SUNY-Downstate Medical Center, Brooklyn, NY

Professional Memberships

American Society of Clinical Oncology (ASCO)
Member, 2008-present
American Society of Pediatric Hematology/Oncology (ASPHO
Member, 2008-present
Children's Oncology Group (COG)
Member, 2008-present

Selected Publications

Peer-Reviewed Original Research Articles

1. Tarek N, Le Luduec JB, Gallagher MM, Zheng J, Venstrom JM, Chamberlain E, Modak S, Heller G, Dupont B, Cheung NK, Hsu KC. Unlicensed NK cells target neuroblastoma following anti-GD2 antibody treatment. J Clin Invest 122(9):3260-3270, 9/4/2012. e-Pub 8/6/2012. PMCID: PMC3428088.
2. Tarek N, Kernan NA, Prockop SE, Sacaradavou A, Small TN, O’Reilly RJ, Boulad F. T-cell-depleted hematopoietic SCT from unrelated donors for the treatment of congenital amegakaryocytic thrombocytopenia. Bone Marrow Tranplant 47(5):744-6, 5/2012.


1. Tarek N, Meighan M, Gallagher JF, Chou MN, Lubin GH, Barker J, Hsu K. KIR and HLA genotypes do not predict unit predominance following double umbilical cord blood transplantation. IHIW, 2012.
2. Tarek N, Le Luduc JB, Gallagher MM, Zheng J, Venstrom JM., Chamberlain E, Modak S, Heller, Dupont B, Cheung NK, Hsu KC. The “missing ligand” effect: unlicensed natural killer cells can dominate tumor killing in the presence of monoclonal antibody. SNI, 2012.
3. Tarek N, Gallager M, Chou JF, Lubin MN, Heller G, Barker J, Hsu KC. KIR-HLA genotypres have no identifiable role in unit predominance following double unit cord blood transplantation. ASBMT, 2011.
4. Gallagher M, Tarek N, Zheng J, Venstrom JM, Cheung IY, Modak S, Dupont B, Cheung NK, Hsu KC. KIR/HLA genotypes Predictive of Missing KIR Ligands are Associated with Improved Outcome in Patients with High-Risk Neuroblastoma Treated with Anti-GD2 Monoclonal Antibody Therapy. ASPHO, 2011.
5. Tarek N, Gallagher MM, Cheung NK, Hsu KC. Normally Hyporesponsive Unlicensed Natural Killer Cells are Strongly Activated by Neuroblastoma (NB) in the presence of Anti-GD2 Monoclonal Antibody (MoAb). ASPHO, 2011.
6. Tarek N, Yu J, Venstrom JM, Hsu KC. Temporary licensing of hyporesponsive NK cells following allogeneic HCT is not affected by T-cells in the stem cell allograft. ASBMT, 2010.

Last updated: 7/11/2014